Suchergebnisse - "Herold, Christoph"

PubPharm (6)

1

723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

enthalten in: Gastroenterology | 2013

von Mauss, S. | Eisenbach, C. | Heyne, R. | +10

2

940 Predicitive Factors for Nonresponse in Genotype 2/3 Infected Chronic Hepatitis C (CHC) Patients Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV) in Real Life Setting

enthalten in: Gastroenterology | 2012

von Petersen, J. | Lutz, T. | Link, R. | +16

3

Sa1072 Early Markers of Metabolic Syndrome are Associated With Distinct HCV Genotypes, While Abnormal Glucose Tolerance Substantially Decreases the Likelihood of SVR

enthalten in: Gastroenterology | 2012

von Jaeckel, E. | Zehnter, E. | Lutz, T. | +15

4

Pathological Glucose Levels and Presence of Hypertension Identifies HCV Patients With Minor Treatment Responses

enthalten in: Gastroenterology | 2011

von Jaeckel, E. | Zehnter, E. | Lutz, T. | +13

5

Changes in ELF Score During Treatment With Pegylated Interferon and Silymarin Are Associated With Progression of Histological Liver Disease in Non-Responder Patients With Chronic Hepatitis C

enthalten in: Gastroenterology | 2011

von Tanwar, S. | Ellis, E. | Parkes, J. | +2

6

Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection

enthalten in: Gastroenterology | 2010

von McHutchison, J. | Goodman, Z. | Patel, K. | +92

ErratumIn: Gastroenterology. 2010 Jul;139(1):360

1
[1]